Regeneron Pharmaceuticals, Inc. (FRA:RGO)

Regeneron Pharmaceuticals Revenue

Regeneron Pharmaceuticals had revenue of $3.03B USD in the quarter ending March 31, 2025, a decrease of -3.70%. This brings the company's revenue in the last twelve months to $14.09B, up 7.52% year-over-year. In the year 2024, Regeneron Pharmaceuticals had annual revenue of $14.20B with 8.27% growth.

• Revenue (ttm): $14.09B
• Revenue Growth: +7.52%
• P/S Ratio: 4.33
• Revenue / Employee: $932.46K
• Employees: 15,106
• Market Cap: 56.43B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.20B	1.08B	8.27%
Dec 31, 2023	13.12B	944.30M	7.76%
Dec 31, 2022	12.17B	-3.90B	-24.26%
Dec 31, 2021	16.07B	7.57B	89.14%
Dec 31, 2020	8.50B	1.94B	29.58%